|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print October 16, 2002
Am J Physiol Gastrointest Liver Physiol, 10.1152/ajpgi.00351.2002
Submitted on August 20, 2002
Accepted on October 7, 2002
1 Department of Anatomy and Neurosciences, University of Texas Medical Branch, Galveston, TX, USA
2 Elim Biopharmaceuticals, Inc., South San Francisco, CA, USA
3 National Cancer Institute, Fredericksburg, MD, USA
4 Department of Physiology, University of Liverpool, Liverpool, United Kingdom
* To whom correspondence should be addressed. E-mail: posingh{at}utmb.edu.
Proliferation and carcinogenesis of the large intestinal epithelial cells is significantly increased in transgenic mice, over-expressing the precursor progastrin (PG) peptide. It is not known if the in vivo growth effects of PG on intestinal epithelial cells (IEC) are mediated directly or indirectly. Full-length recombinant human PG (rhPG1-80) was generated to examine possible direct effects of PG on IEC cells. Surprisingly rhPG (01.-1.0 nM) was more effective than the completely processed G17 peptide as a growth factor. Even though IEC cells did not express CCK1 and CCK2-receptors (R), fluorescently labeled G17 and gly-extended G17 (G-Gly) were specifically bound to the cells, suggesting the presence binding proteins other than CCK1 and CCK2-R on IEC cells. High affinity (Kd = 0.5-1.0 nM) binding sites for 125I-rhPG were discovered on IEC cells that demonstrated relative binding affinity for gastrin-like peptides in the order PG
C-terminally extended G17 by 8 amino acids (G17-CT)
G-Gly>G17>*CCK-8 (*=p<0.05). In conclusion, our studies demonstrate for the first time direct growth effects of the full-length precursor peptide on IEC cells, in vitro, that are apparently mediated by the high affinity PG binding sites that were discovered on these cells.
This article has been cited by other articles:
![]() |
W. Rengifo-Cam, S. Umar, S. Sarkar, and P. Singh Antiapoptotic Effects of Progastrin on Pancreatic Cancer Cells Are Mediated by Sustained Activation of Nuclear Factor-{kappa}B Cancer Res., August 1, 2007; 67(15): 7266 - 7274. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dufresne, C. Seva, and D. Fourmy Cholecystokinin and gastrin receptors. Physiol Rev, July 1, 2006; 86(3): 805 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ferrand, C. Bertrand, G. Portolan, G. Cui, J. Carlson, L. Pradayrol, D. Fourmy, M. Dufresne, T. C. Wang, and C. Seva Signaling Pathways Associated with Colonic Mucosa Hyperproliferation in Mice Overexpressing Gastrin Precursors Cancer Res., April 1, 2005; 65(7): 2770 - 2777. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wu, A. Owlia, and P. Singh Precursor peptide progastrin1-80 reduces apoptosis of intestinal epithelial cells and upregulates cytochrome c oxidase Vb levels and synthesis of ATP Am J Physiol Gastrointest Liver Physiol, December 1, 2003; 285(6): G1097 - G1110. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |